Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design.
CONCLUSIONS: The Bayesian paradigm represents a novel and promising approach in device-based hypertension trials.
CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02439749 (SPYRAL HTN-OFF MED Pivotal) and NCT02439775 (SPYRAL HTN-ON MED Expansion).
PMID: 32034481 [PubMed - as supplied by publisher]
Source: Clin Med Res - Category: Research Authors: Böhm M, Townsend RR, Kario K, Kandzari D, Mahfoud F, Weber MA, Schmieder RE, Tsioufis K, Hickey GL, Fahy M, DeBruin V, Brar S, Pocock S Tags: Clin Res Cardiol Source Type: research
More News: Cardiology | Clinical Trials | Heart | History of Medicine | Hypertension | Research | Study